Introduction
lrbiquitin is a highly conserved eukaryotic protein that has been suggested to play a role in intracellular protein degradation [ 1 1, cell cycle regulation [2-41, DNA repair [ 5 1, recombination [6], chromatin structure [7] , stress response [8, 91, programmed cell death [ 101, the mechanism of receptor action 11 1, 121 and ribosome biogenesis [ 13, 141. In all cases it appears to exert its function by being covalently attached to target proteins by an amide bond between the C-terminal glycine of ubiquitin and an a-or &-amino group on the attached protein [ 1, 151. At least three types of ubiquitin-protein bonds have been characterized.
In the first type of linkage, ubiquitin-protein conjugates are linked by an amide bond between the C-terminus of ubiquitin and &-amino groups on cellular proteins. This widespread post-translational modification of proteins is thought to target the attached protein for various metabolic fates [ 151. In the case of targeting for proteolysis (Fig. l) , polyubiquitination of substrate proteins is observed.
In this second type of linkage, poly-ubiquitin 'chains' are linked by amide bonds between the Cterminus of ubiquitin and the side chain amino group of I,ys-48 on the neighbouring ubiquitin. These poly-ubiquitinated proteins are recognized and degraded by specific proteases of the cell [ 11.
1 lydrolysis of this poly-ubiquitin chain must occur in order for ubiquitin to become available for another catalytic cycle. In contrast, the reversible ubiquitination of histones is limited to one or two Three eukaryotic genes [ 161 code for two proteins that consist of an N-terminal ubiquitin and a Cterminal ribosomal protein (Ub-CEP52 and Ub-CEPHO). Deletion of these genes results in cells that are defective in assembling intact ribosomes. It has recently been suggested that the expression of these ribosomal proteins as ubiquitin fusions may assist in ribosomal assembly but is not necessary for function [ 131. The ubiquitin is proteolytically processed from these proteins at a poorly defined point in the maturation of the ribosome. A fourth ubiquitin gene codes for a ubiquitin precursor (pro-IJb) containing 6-12 repeats of the ubiquitin sequence.
These repeats are arranged in a head-to-tail fashion with no linker peptides at the monomer junctions. A consensus heat-shock promoter is present in the 5' regulatory region of this gene and ubiquitin is a heat-shock protein 18, 91. Its role in stress response is undefined, but it may be induced to furnish enough new ubiquitin to accomplish the increased protein degradation observed in stress. Deletions of this gene in yeast result in cells that fail to sporulate, don't survive heat-shock, and grow poorly under stress [17] . This pro-protein is very rapidly pro- 
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The reactions are divided into four categories activation of the C-terminus of ubiquitin by the activating enzyme and transfer as a thiol ester t o E2, one of a family of carrier proteins. conlugation of ubiquitin t o the &-amino groups of target proteins or t o itself in reactions catalysed by E 2 or by E2 with the assistance of a Iigase, E3, deconjugation of ubiquitin by proteolysis of the isoamide bond, a reaction that could inhibit proteolysis by lowering the steady-state level of poly-ubiquitinated substrate or increase the rate by disassembling the poly-ubiquitin chain t o release free ubiquitin for another catalytic cycle, and proteolysis of the poly-ubiquitinated substrate by a 26 S multi-catalytic proteinase Deconjugation Proteolysis cessed to monomeric ubiquitin by an unidentified protease.
Finally, there are other genes that encode ubiquitin-related proteins. An interferon-induced protein [ 181 has been described which appears to have evolved by a gene duplication of a ubiquitincoding sequence. This protein is synthesized as a 17 kDa precursor and subsequently processed to a 15 kDa mature form by the release of a C-terminal peptide. The site of cleavage ( A ) is precisely at the position corresponding to the C-terminus of ubiquitin (. . . LRGGAGTEPGGRS). Thus, the processing of this gene product resembles that of the other ubiquitin gene products in the involvement of a protease with specificity for cleavage to the Cterminal side of Gly-Gly bonds in ubiquitin or related sequences. Other examples of the processing of ubiquitin-like proteins occur in viruses (baculovirus and bovine viral diarrhea virus) which have incorporated pieces of host ubiquitin genes into the viral poly-protein genes [ 161.
Ubiquitin C-terminal hydrolases
It is clear that there are a number of steps in ubiquitin metabolism that require proteolytic processing by cleavage of amide bonds at the C-terminus of ubiquitin. Ubiquitin C-terminal hydrolases (UCHs) are a class of cytoplasmic thiol proteases with specificity for cleavage of esters and amides of the C-terminal glycine of ubiquitin. Enzymes with this catalytic activity are required for the processing of all known ubiquitin gene products (see above) and metabolites ( Fig. 1) .
In the ubiquitin-dependent proteolysis reaction ( Fig. 1 ) the action of these enzymes could both stimulate and inhibit protein degradation. Inhibition could result from the deconjugation of ubiquitin from either mono-or poly-ubiquitinated protein substrates. These reactions reverse the conjugation of ubiquitin and are thus components of a 'futile cycle'. As such we are tempted to think of these as regulatory steps and not 'futile'. The action of ubiquitin C-terminal hydrolases could also stimulate degradation by increasing the steady-state level of free ubiquitin upon the hydrolysis of polyubiquitin chains or any adventitiously formed adducts between ubiquitin and small-molecularweight nucleophiles. Clearly it is important to understand which enzymes catalyse these reactions and to determine their distribution and regulation. W e set out to identify and characterize these enzymes using a generic substrate, ubiquitin Cterminal ethyl ester [ 191. 
four lJCH isozymes from bovine thymus [20] , and cloned a human c1)NA for the major thymus isozyme. IJCH-I,.? (211. Fig. 2 shows that IJCH-I,.?
(bottom line) is a member of a newly recognized gene family. In these alignments, only identical residues are boxed and then only if they appear in at least three of the five sequences. The first sequence shows the similarity of IJC€I-I,3 to a yeast protein (221 which exhibits the same catalytic activity, i.e., cleavage of C-terminal esters and amides of ubiquitin. The second sequence demonstrates that a similar degree of identity is observed with a newly A few conclusions can be made from these alignments. First, these enzymes are thiol proteases based on their sensitivity to inhibitors [21, 221 and this implies that Cys-100 (the only conserved cysteine in these sequences) must be the active site thiol. Second, there is a conserved histidine at position 107 which may furnish the required acidlbase catalysis of tetrahedryl intermediate formation and decay. Finally, the active-site sequences are unrelated to any other known thiol proteases. The sequences are conserved as strongly across species as they are among isozymes, suggesting significant evolutionary pressure for the maintenance of these active structures throughout development.
The ubiquitin system in neural tissues
Since the original observations that Alzheimer's disease plaques show ubiquitin irnmunostaining immunostaining has been observed in cases involving deposition of abnormal proteins, particularly cytoskeletal and neurofilament proteins. This fact, and the fact that ubiquitin is a stress protein, suggests that ubiquitin is found in these inclusions because it is intimately involved in the degradation of these abnormal protein deposits. It is not known whether ubiquitin is present at the time of deposition or is only detected late in the process as a reflection of the cell's attempt to deal with this pathological situation.
This question may be clarified by characterizing when the enzymes that metabolize ubiquitin become associated with these lesions. As discussed above, PCP 9.5 (UCH-I,3) is a ubiquitin C-terminal hydrolase present in neural tissues. This enzyme could potentially play a role in proof-reading [28] by removing ubiquitin from those native proteins that are not destined for degradation. Hy removing ubiquitin from conjugates, it could slow the rates of proteolysis. As shown in Fig. 1, it could also increase the rates of proteolysis by deconjugating ubiquitin from the multi-ubiquitin chains as the attached protein is being degraded [29] .
When a variety of neurological tissues were immunostained for the presence of PGP 9.5, it was found that the enzyme is selectively accumulated in inclusion bodies characteristic of neurodegenerative diseases [30] . This may indicate that active ubiquitin metabolism is occurring under these circumstances. It is not yet clear whether this metabolism is an early or late event in the pathology because of the uncertain temporal relationship of the various pathological lesions observed during disease progression. A striking confirmation of this conclusion is proffered by the finding that the putative ubiquitin-dependent protease and IJCI I-Ill (PCP 9.5) are similarly localized, i.e., both are found in cortical Lewy bodies and loosely arranged globose-type neurofibrillary tangles [31].
W e thus conclude that active ubiquitin metabolism is associated with neuronal damage and is most likely part of the stress response system. Many immunocytochemical observations have suggested an increase in conjugated ubiquitin occurs in response to various diseases and to enviroomental insults. This presumably requires an increased expression of ubiquitin. Indeed, the stress-induced poly-ubiquitin mRNA is elevated in motor neuron disease [32] and in normal brain during fever or ischemia [ 3 31.
Tissue distribution of UCH isozymes
In light of the extremely specific localization of isozyme I,1 (PCP 9.9, it was of interest to examine the distribution of the other isozymes. The long-term objectives of our studies are to identify and characterize these related proteins, to determine the tissue distribution and regulation of the isozymes, to define the substrate specificity of these enzymes, and to elucidate the physiological role(s) for these enzymes.
Two independent approaches were taken to characterize the distribution and regulation of these enzymes. The first is an immunochemical approach. Polyclonal antibodies against homogeneous bovine UCH-Ill (PCP 9.5) and UCH-I,3 were raised in rabbits. The antibodies were then affinity purified by adsorption to and elution from nitrocellulose strips containing electrophoretically purified 1JCII isozymes. These antibodies cross-react with the corresponding isozymes from rat and human tissues. Anti-I,1 detects only isozyme L1 while anti-I,3 detects both isozyme 1 2 and IJ. In addition, several higher-molecular-weight species are detected in different tissues. Hecause the molecular weights of the UCH isozymes are slightly different, SDS-PAGE and Western blots of tissue and cell homogenates can define the isozyme content of these samples. The second approach depends on the fact that the three mammalian isozymes can be separated by ion-exchange chromatography [20] . The f.p.1.c. of tissue and cell homogenates and assay of the separated isozymes using ubiquitin ethyl ester allows us to characterize the amounts of each isozyme activity. Changes in isozyme profiles can be conveniently followed by this technique. As these results agree with the immunochemical measurements, we will discuss only the latter. Looking first at the UCH isozyme patterns, it is apparent that there is considerable tissue specificity in the distribution of UCH isozymes Ill and 1,3. As expected, we see the I,1 isozyme (neuronal PCP 9.5) in brain and the testis, a highly innervated tissue. There are also trace amounts detected in heart. Most tissues examined (except erythrocytes) contained significant amounts of L2 and we postulate that this is a constitutive or 'housekeeping' enzyme. Isozyme I,3 is found in red cells (and other hematopoetic cells), lung and brain. Its presence in the last two tissues may be down to the contamination of macrophages and blood cells in these preparations.
In tissue culture, the homogeneity of cell type makes the distribution clearer. Neuronal cell types (PC-12 and Neuro-2A) contain only UCH-L1 (PCP 9.5). HEI, 299 (a human lung fibroblast) and Vero (an African green monkey kidney fibroblast) both contain small amounts of UCH-L1 (PGP 9.5). This is consistent with a recent report that (American type culture collection # CCL171 lung Volume 20 Table I Distribution of anti-UCH immunoreactivity in extracts from mouse tissues and cell lines Tissues were homogenized and 100000 g supernatents were subjected to SDS-PAGE and Western blotting Tissue culture cells were harvested by centrifugation or scraping and suspended directly in SDS sample buffer All samples were clarified by centrifugation prior to loading on the gels A 50 p g sample of protein was loaded in each lane and the intensity of the immunostained band was scored from one plus for a barely detectable band to three plus for a band equivalent in intensity t o 500 ng of control UCH Primary chicken hepatocyte cultures (cHEP) contain primarily isozyme L2, in good agreement with the data described above. I,K 35.2, a hybridoma, contains both 1 2 (from the spleen cells?) and I,3 (from the lymphoma cells?). Y 1 ~ an epithelial-like adrenal carcinoma contains both L2 and 1,3 whereas Raji, a H-cell lymphoma, contains predominantly isozyme I,3.
The generalizations that emerge are that isozynie I l l is strongly expressed in neuronal, neuroendocrine and perhaps some fetal fibroblasts.
Isozyme I,3 is present mainly in hematopoetic cells.
Many tissues and cells contain significant amounts of isozyme 1 2 which may be a constitutive isozyme.
Regulation of UCH gene expression
Hecause ubiquitin is a heat-shock protein, and the levels of UCI-I-Ll (PCP 9.5) are increased in neurological disease 1.301, it was of interest to determine if the expression of UCH isozymes was affected by stress. Cells were heat-shocked or treated with sodium arsenite and the levels of IJCH and heatshock protein 70 (hsp70) imrnunoreactivity were determined by SDS-PAGE and Western blotting.
There was no change in the level of any lJCII isozymes in PC12, HEI, 299, I,K 35.2, Y 1 or Kaji cells under conditions where hsp70 was strongly induced. These results indicate that it is unlikely that expression of these enzymes is under regulation by conventional stress-response elements.
We also investigated the effects of serum deprivation, differentiation by nerve growth factor and seeding density on the isozymes expressed in PC12 cells. In short, none of these factors caused a change in the amounts of isozymes expressed. Treatment of Raji cells with phorbol 12-myristate 13-acetate (PMA) caused a twofold increase in the low levels of UCH-L1 (PGP 9.5) seen in these cells. Compared to the data presented in Table 1 , much higher amounts of Raji extracts must be loaded on SDS-PAGE in order to detect endogenous UCH-1,l (PGP 9.5) and the induced levels. Thus, even in the presence of PMA, the levels of expression are 10-fold lower than those detected in the experiments of Table 1 . Although this may indicate regulation of I,1 expression via protein kinase C, the stimulation by PMA is not apparent in other cell types tested. Thus, we are not certain of the generality of this observation.
Distribution of other UCHimmunoreactive proteins
A small number of larger-molecular-weight proteins were also observed to cross-react with antibodies to UCH isozymes. A protein of approximately 50 kDa and cross-reactive with anti-L3 was observed in heart, kidney, liver and epithelial-like cells (Y 1). Anti-L1 antibodies detected bands at approximately 80 and 90 kDa in many tissues, but not in the cell lines tested. Finally, red cells contain protein staining as a diffuse band of approximately 60 kDa and cross-reactive with both anti-Ll and anti-13. In spite of the fact that these antibodies were affinity-purified, we currently do not know the basis for such cross-reactivity. It may be that there are shared epitopes on a small number of otherwise unrelated proteins, or it may be that there are related proteins yet to be described. We are currently characterizing some of these proteins to clarify these findings.
Conclusions
A clear understanding of the role(s) of these isozymes awaits identification of physiological substrates. At the moment we can only speculate on these roles. UCH-L1 (PCP 9.5) is clearly involved in some neuronal-specific function, perhaps related to stress response. It is not a conventional heatshock protein (see above). As it is transported by the slow SCb transport pathway in neurons [XI, it is difficult to see how it could be involved in a rapid response in the nerve termini. It could, however, be constitutively expressed in these tissues or rapidly accumulated in the cell body. In the absence of any other evidence, we hypothesize that it is involved in the co-translational processing of the pro-ubiquitin gene product induced by stress response. Its accumulation in neuronal lesions may simply reflect its binding afinity for the poly-ubiquitin which accumulates at these sites. Hematopoetic cells, on the other hand, may have less need for this type of stress response but would need to process the ubiquitin zinc finger gene products in order to rapidly synthesize the ribosomes required for these cells to undergo rapid clonal expansion. Thus, isozyme IA3 may be involved in co-translational processing of these proteins in rapidly dividing cells. Isozyme 1 2 is much more widely distributed and could play a role in removing ubiquitin from peptides generated as degradation intermediates or in salvaging ubiquitin which may have been adventitiously trapped by reaction with small cellular amines and thiols.
These speculations suggest ideas for direct experiments to test the specificity of catalysis by these isozymes. Such experiments are underway and preliminary results show clear differences in specificity. Much more work will be needed to clarify the differences in ubiquitin metabolism and the roles of this gene family in development and maintenance of tissue function.
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